I. Wittmann

399eP COVID-19-associated disruptions and incomplete recovery of lung cancer incidence and mortality: A nationwide Hungarian analysis (2011-2023)

Zsolt Pápai-Székely, T. Szabo, Zoltán Kiss, G. Molnar et autres

Lung cancer (LC) outcomes are highly sensitive to diagnostic delays. Using nationwide real-world data from Hungary, we evaluated how the COVID-19 pandemic affected LC incidence and mortality across the pre-COVID (2011-2019), COVID-19 pandemic (2020-2021), and post-COVID (2022-2023) periods.

hu (code pays fourni par la source)

95P Improving real-world survival in late-stage NSCLC across the pre-immunotherapy, COVID, and post-COVID eras: A nationwide HeLP3 analysis (2011-2024)

Zoltán Kiss, G. Molnar, T. Szabo, M. Darida et autres

The management of advanced non-small cell lung cancer (NSCLC) has evolved markedly over the past decade with the introduction of immune checkpoint inhibitors (IO), while the COVID-19 pandemic posed substantial challenges to cancer care delivery. Within the Hungarian Lung Cancer Real-World Evidence …

hu (code pays fourni par la source)

397eP Significant decline in tobacco-related cancers among middle-aged adults: Nationwide evidence from Hungary (2011-2023)

Z. Kiss, G. Molnar, T. Szabo, M. Darida et autres

hu (code pays fourni par la source)